| Entry |
|
|---|
| Name |
Pirmagrel (USAN/INN);
CGS 13080 |
|---|
| Formula |
C13H16N2O2
|
|---|
| Exact mass |
232.1212
|
|---|
| Mol weight |
232.28
|
|---|
| Structure |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
|
|---|
| Efficacy |
Platelet aggregation inhibitor, Thromboxane A2 (TXA2) synthase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
D05502 Pirmagrel
Target-based classification of drugs [BR:br08310]
Enzymes
Isomerases (EC5)
Thromboxane-A synthase
TBXAS1 (CYP5A1)
D05502 Pirmagrel (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C8x C 9.9400 -17.6400
2 C8x C 9.9400 -19.0400
3 C8y C 11.1524 -19.7400
4 N4y N 12.3649 -19.0400
5 C8y C 12.3649 -17.6400
6 C8x C 11.1524 -16.9400
7 C8x C 13.6964 -19.4726
8 N5x N 14.5193 -18.3400
9 C8x C 13.6964 -17.2074
10 C1b C 11.1524 -21.1398
11 C1b C 9.9232 -21.8497
12 C1b C 8.7192 -21.1546
13 C1b C 7.5363 -21.8377
14 C1b C 6.3427 -21.1485
15 C6a C 5.1545 -21.8346
16 O6a O 3.9636 -21.1470
17 O6a O 5.1544 -23.2398
BOND 18
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 2
9 8 9 1
10 5 9 2
11 3 10 1
12 10 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 14 15 1
17 15 16 1
18 15 17 2
|
|---|
